- •There is an inverse association between coffee consumption and non-motor symptoms (NMSs) of drug-naïve PD patients.
- •Coffee drinkers had a lower severity in several sub-items of the mood/cognition domain compared to non-coffee drinkers.
- •It is important to consider the history of coffee consumption in the assessment of NMSs of PD patients.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Neuropathological basis of nonmotor manifestations of Parkinson's disease.Mov. Disord. 2016; 31: 1114-1119
- Determinants of health-related quality of life in Parkinson's disease: a systematic review.Park. Relat. Disord. 2011; 17: 1-9
- Non-recognition of depression and other non-motor symptoms in Parkinson's disease.Park. Relat. Disord. 2002; 8: 193-197
- Recent developments in pain in dementia.BMJ. 2005; 330: 461-464
- The non-motor symptom complex of Parkinson's disease: a comprehensive assessment is essential.Curr. Neurol. Neurosci. Rep. 2005; 5: 275-283
- Association of coffee and caffeine intake with the risk of Parkinson disease.J. Am. Med. Assoc. 2000; 283: 2674-2679
- A retrospective study of smoking in Parkinson's disease.Am. J. Epidemiol. 1968; 88: 149-158
- Diet and Parkinson's disease. I: a possible role for the past intake of specific foods and food groups. Results from a self-administered food-frequency questionnaire in a case-control study.Neurology. 1996; 47: 636-643
- Nutritional and occupational factors influencing the risk of Parkinson's disease: a case-control study in southeastern Sweden.Mov. Disord. 1999; 14: 28-37
- Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease.J. Neurosci. 2001; 21 (RC143)
- Role of adenosine A2A receptors in parkinsonian motor impairment and l-DOPA-induced motor complications.Prog. Neurobiol. 2007; 83: 293-309
- Targeting adenosine A2A receptors in Parkinson's disease.Trends Neurosci. 2006; 29: 647-654
- The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service.Brain. 2002; 125: 861-870
- Second consensus statement on the diagnosis of multiple system atrophy.Neurology. 2008; 71: 670-676
- Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.Neurology. 1996; 47: 1-9
- Cortical basal ganglionic degeneration presenting with "progressive loss of speech output and orofacial dyspraxia".J. Neurol. Neurosurg. Psychiatry. 1992; 55: 1101
- Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop.J. Alzheimers. Dis. 2006; 9: 417-423
- The metric properties of a novel non-motor symptoms scale for Parkinson's disease: results from an international pilot study.Mov. Disord. 2007; 22: 1901-1911
- Assessment of depression: the depression inventory.Mod. Probl. Pharmacopsychiatr. 1974; 7: 151-169
- A validity study on the Korean Mini-Mental State Examination (K-MMSE) in dementia patients.J. Korean. Neurol. Assoc. 1997; 15: 300-308
- Meta-analysis of early nonmotor features and risk factors for Parkinson disease.Ann. Neurol. 2012; 72: 893-901
- Prospective study of caffeine consumption and risk of Parkinson's disease in men and women.Ann. Neurol. 2001; 50: 56-63
- Coffee and tea consumption and the risk of Parkinson's disease.Mov. Disord. 2007; 22: 2242-2248
- Voluptuary habits and clinical subtypes of Parkinson's disease: the FRAGAMP case-control study.Mov. Disord. 2010; 25: 2387-2394
- FRAGAMP Study Group, Coffee consumption and risk of levodopa-induced dyskinesia in Parkinson's disease: the FRAGAMP study.Mov. Disord. 2015; 30: 1854-1856
- A new proposed guidance system for beverage consumption in the United States.Am. J. Clin. Nutr. 2006; 83: 529-542
- Coffee and caffeine consumption and depression: a meta-analysis of observational studies.Aust. N. Z. J. Psychiatr. 2016; 50: 228-242
- Pathophysiological roles for purines: adenosine, caffeine and urate.Prog. Brain Res. 2010; 183: 183-208
- Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment.Lancet Neurol. 2009; 8: 464-474
- Effects of caffeine in Parkinson's disease: from neuroprotection to the management of motor and non-motor symptoms.J. Alzheimers. Dis. 2010; 20: S205-S220